Adoptive transfer of M2 macrophages promotes locomotor recovery in adult rats after spinal cord injury

Brain, Behavior, and Immunity

Volumn 45, Issue , 2015, Pages 157-170

  Ma, Shan Feng ^a   Chen, Yue Juan ^a   Zhang, Jing Xing ^a   Shen, Lin ^a   Wang, Rui ^a   Zhou, Jian Sheng ^a   Hu, Jian Guo ^a   Lü, He Zuo ^a  

^a BENGBU MEDICAL COLLEGE   (China)

Author keywords

Adoptive transfer; Locomotor recovery; Macrophage polarization; Microenvironment; Spinal cord injury

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 6; NITRIC OXIDE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; IL1B PROTEIN, RAT; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; NOS2 PROTEIN, RAT;

ADOPTIVE TRANSFER; ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASSO BEATTIE AND BRESNAHAN LOCOMOTOR RATING SCALE; BONE MARROW DERIVED MACROPHAGE; BONE MARROW TRANSPLANTATION; CELL INFILTRATION; CELL STIMULATION; CELL TRANSFER; FEMALE; FOOTPRINT TEST; IMMUNOHISTOCHEMISTRY; MACROPHAGE ACTIVATION; MICROGLIA; MYELINATION; NERVE FIBER; NEUROPROTECTION; NONHUMAN; POLARIZATION; PRESERVATION; PRIORITY JOURNAL; RAT; RATING SCALE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPINAL CORD INJURY; SPINAL CORD LESION; TH1 CELL; TH2 CELL; ANIMAL; CONVALESCENCE; GENETICS; IMMUNOLOGY; INFLAMMATION; LOCOMOTION; MACROPHAGE; METABOLISM; MYELIN SHEATH; PATHOLOGY; PATHOPHYSIOLOGY; TRANSPLANTATION;

ADOPTIVE TRANSFER; ANIMALS; AXONS; FEMALE; INFLAMMATION; INTERLEUKIN-10; INTERLEUKIN-13; INTERLEUKIN-1BETA; INTERLEUKIN-6; LOCOMOTION; MACROPHAGES; MICROGLIA; MYELIN SHEATH; NITRIC OXIDE SYNTHASE TYPE II; RATS; RECOVERY OF FUNCTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPINAL CORD INJURIES; TH2 CELLS; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84924177414     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2014.11.007     Document Type: Article

References (60)

1. Bartholdi D., Schwab M.E. Expression of pro-inflammatory cytokine and chemokine mRNA upon experimental spinal cord injury in mouse: an in situ hybridization study. Eur. J. Neurosci. 1997, 9:1422-1438.
2. Basso D.M., Beattie M.S., Bresnahan J.C. A sensitive and reliable locomotor rating scale for open field testing in rats. J. Neurotrauma 1995, 12:1-21.
3. Basso D.M., Beattie M.S., Bresnahan J.C., Anderson D.K., Faden A.I., Gruner J.A., Holford T.R., Hsu C.Y., Noble L.J., Nockels R., Perot P.L., Salzman S.K., Young W. MASCIS evaluation of open field locomotor scores: effects of experience and teamwork on reliability. Multicenter Animal Spinal Cord Injury Study. J. Neurotrauma 1996, 13:343-359.
4. Bethea J.R. Spinal cord injury-induced inflammation: a dual-edged sword. Prog. Brain Res. 2000, 128:33-42.
5. Bethea J.R., Nagashima H., Acosta M.C., Briceno C., Gomez F., Marcillo A.E., Loor K., Green J., Dietrich W.D. Systemically administered interleukin-10 reduces tumor necrosis factor-alpha production and significantly improves functional recovery following traumatic spinal cord injury in rats. J. Neurotrauma 1999, 16:851-863.
6. Binder S.W., Said J.W., Shintaku I.P., Pinkus G.S. A histiocyte-specific marker in the diagnosis of malignant fibrous histiocytoma. Use of monoclonal antibody KP-1 (CD68). Am. J. Clin. Pathol. 1992, 97:759-763.
7. Bowes A.L., Yip P. Modulating inflammatory cell responses to spinal cord injury: all in good time. J. Neurotrauma 2014, 31:1753-1766.
8. Cao Q., Zhang Y.P., Iannotti C., DeVries W.H., Xu X.M., Shields C.B., Whittemore S.R. Functional and electrophysiological changes after graded traumatic spinal cord injury in adult rat. Exp. Neurol. 2005, 191(Suppl. 1):S3-S16.
9. Chen J.F., Ni H.F., Pan M.M., Liu H., Xu M., Zhang M.H., Liu B.C. Pirfenidone inhibits macrophage infiltration in 5/6 nephrectomized rats. Am. J. Physiol. Renal Physiol. 2013, 304:F676-F685.
10. Clayton J.P., Gammon G.M., Ando D.G., Kono D.H., Hood L., Sercarz E.E. Peptide-specific prevention of experimental allergic encephalomyelitis. Neonatal tolerance induced to the dominant T cell determinant of myelin basic protein. J. Exp. Med. 1989, 169:1681-1691.
11. Davies J.Q., Gordon S. Isolation and culture of murine macrophages. Methods Mol. Biol. 2005, 290:91-103.
12. Eligini S., Crisci M., Bono E., Songia P., Tremoli E., Colombo G.I., Colli S. Human monocyte-derived macrophages spontaneously differentiated in vitro show distinct phenotypes. J. Cell. Physiol. 2013, 228:1464-1472.
13. Fuentes-Duculan J., Suarez-Farinas M., Zaba L.C., Nograles K.E., Pierson K.C., Mitsui H., Pensabene C.A., Kzhyshkowska J., Krueger J.G., Lowes M.A. A subpopulation of CD163-positive macrophages is classically activated in psoriasis. J. Invest. Dermatol. 2010, 130:2412-2422.
14. Goerdt S., Orfanos C.E. Other functions, other genes: alternative activation of antigen-presenting cells. Immunity 1999, 10:137-142.
15. Hayakawa K., Okazaki R., Morioka K., Nakamura K., Tanaka S., Ogata T. Lipopolysaccharide preconditioning facilitates M2 activation of resident microglia after spinal cord injury. J. Neurosci. Res. 2014, 92:1647-1658.
16. Hu J.G., Shen L., Wang R., Wang Q.Y., Zhang C., Xi J., Ma S.F., Zhou J.S., Lu H.Z. Effects of Olig2-overexpressing neural stem cells and myelin basic protein-activated T cells on recovery from spinal cord injury. Neurotherapeutics 2012, 9:422-445.
17. Huang Y., Luo F., Li H., Jiang T., Zhang N. Conditioned medium from alternatively activated macrophages induce mesangial cell apoptosis via the effect of Fas. Exp. Cell Res. 2013, 319:3051-3057.
18. Ishii H., Jin X., Ueno M., Tanabe S., Kubo T., Serada S., Naka T., Yamashita T. Adoptive transfer of Th1-conditioned lymphocytes promotes axonal remodeling and functional recovery after spinal cord injury. Cell Death Dis. 2012, 3:e363.
19. Karimi-Abdolrezaee S., Eftekharpour E., Wang J., Morshead C.M., Fehlings M.G. Delayed transplantation of adult neural precursor cells promotes remyelination and functional neurological recovery after spinal cord injury. J. Neurosci. 2006, 26:3377-3389.
20. Kigerl K.A., Gensel J.C., Ankeny D.P., Alexander J.K., Donnelly D.J., Popovich P.G. Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J. Neurosci. 2009, 29:13435-13444.
21. Kipnis J., Mizrahi T., Hauben E., Shaked I., Shevach E., Schwartz M. Neuroprotective autoimmunity: naturally occurring CD4+ CD25+ regulatory T cells suppress the ability to withstand injury to the central nervous system. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:15620-15625.
22. Lee J.Y., Kim H.S., Choi H.Y., Oh T.H., Yune T.Y. Fluoxetine inhibits matrix metalloprotease activation and prevents disruption of blood-spinal cord barrier after spinal cord injury. Brain 2012, 135:2375-2389.
23. Lu H.Z., Xu L., Zou J., Wang Y.X., Ma Z.W., Xu X.M., Lu P.H. Effects of autoimmunity on recovery of function in adult rats following spinal cord injury. Brain Behav. Immun. 2008, 22:1217-1230.
24. Martinez F.O., Sica A., Mantovani A., Locati M. Macrophage activation and polarization. Front. Biosci. 2008, 13:453-461.
25. McWhorter F.Y., Wang T., Nguyen P., Chung T., Liu W.F. Modulation of macrophage phenotype by cell shape. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:17253-17258.
26. Metz G.A., Merkler D., Dietz V., Schwab M.E., Fouad K. Efficient testing of motor function in spinal cord injured rats. Brain Res. 2000, 883:165-177.
27. Michel R.P., Cruz-Orive L.M. Application of the Cavalieri principle and vertical sections method to lung: estimation of volume and pleural surface area. J. Microsc. 1988, 150:117-136.
28. Mikita J., Dubourdieu-Cassagno N., Deloire M.S., Vekris A., Biran M., Raffard G., Brochet B., Canron M.H., Franconi J.M., Boiziau C., Petry K.G. Altered M1/M2 activation patterns of monocytes in severe relapsing experimental rat model of multiple sclerosis. Amelioration of clinical status by M2 activated monocyte administration. Mult. Scler. 2011, 17:2-15.
29. Mohamed-Ali H., de Souza P., Shakibaei M., Hecker-Kia A., Kolkenbrock H., Merker H.J. Synovial and peritoneal macrophages in organoid culture. Histol. Histopathol. 1995, 10:393-403.
30. Mosser D.M., Edwards J.P. Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 2008, 8:958-969.
31. Mulder R., Banete A., Basta S. Spleen-derived macrophages are readily polarized into classically activated (M1) or alternatively activated (M2) states. Immunobiology 2014, 219:737-745.
32. Nakamura M., Houghtling R.A., MacArthur L., Bayer B.M., Bregman B.S. Differences in cytokine gene expression profile between acute and secondary injury in adult rat spinal cord. Exp. Neurol. 2003, 184:313-325.
33. Nakamura M., Okada S., Toyama Y., Okano H. Role of IL-6 in spinal cord injury in a mouse model. Clin. Rev. Allergy Immunol. 2005, 28:197-204.
34. Noble L.J., Wrathall J.R. Distribution and time course of protein extravasation in the rat spinal cord after contusive injury. Brain Res. 1989, 482:57-66.
35. Noble L.J., Donovan F., Igarashi T., Goussev S., Werb Z. Matrix metalloproteinases limit functional recovery after spinal cord injury by modulation of early vascular events. J. Neurosci. 2002, 22:7526-7535.
36. Offner H., Subramanian S., Wang C., Afentoulis M., Vandenbark A.A., Huan J., Burrows G.G. Treatment of passive experimental autoimmune encephalomyelitis in SJL mice with a recombinant TCR ligand induces IL-13 and prevents axonal injury. J. Immunol. 2005, 175:4103-4111.
37. Oorschot D.E. Are you using neuronal densities, synaptic densities or neurochemical densities as your definitive data? There is a better way to go. Prog. Neurobiol. 1994, 44:233-247.
38. Parsa R., Andresen P., Gillett A., Mia S., Zhang X.M., Mayans S., Holmberg D., Harris R.A. Adoptive transfer of immunomodulatory M2 macrophages prevents type 1 diabetes in NOD mice. Diabetes 2012, 61:2881-2892.
39. Penjweini R., Loew H.G., Hamblin M.R., Kratky K.W. Long-term monitoring of live cell proliferation in presence of PVP-Hypericin: a new strategy using ms pulses of LED and the fluorescent dye CFSE. J. Microsc. 2012, 245:100-108.
40. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001, 29:e45.
41. Piao M.S., Lee J.K., Jang J.W., Hur H., Lee S.S., Xiao L., Kim H.S. Melatonin improves functional outcome via inhibition of matrix metalloproteinases-9 after photothrombotic spinal cord injury in rats. Acta Neurochir. (Wien) 2014, 156:2173-2182.
42. Plemel J.R., Wee Yong V., Stirling D.P. Immune modulatory therapies for spinal cord injury - past, present and future. Exp. Neurol. 2014, 258C:91-104.
43. Popovich P.G., Horner P.J., Mullin B.B., Stokes B.T. A quantitative spatial analysis of the blood-spinal cord barrier. I. Permeability changes after experimental spinal contusion injury. Exp. Neurol. 1996, 142:258-275.
44. Popovich P.G., Stokes B.T., Whitacre C.C. Concept of autoimmunity following spinal cord injury: possible roles for T lymphocytes in the traumatized central nervous system. J. Neurosci. Res. 1996, 45:349-363.
45. Romagnani S. T-cell subsets (Th1 versus Th2). Ann. Allergy Asthma Immunol. 2000, 85:9-18. (Quiz 18, 21).
46. Schroeter M., Jander S. T-cell cytokines in injury-induced neural damage and repair. Neuromol. Med. 2005, 7:183-195.
47. Shechter R., Miller O., Yovel G., Rosenzweig N., London A., Ruckh J., Kim K.W., Klein E., Kalchenko V., Bendel P., Lira S.A., Jung S., Schwartz M. Recruitment of beneficial M2 macrophages to injured spinal cord is orchestrated by remote brain choroid plexus. Immunity 2013, 38:555-569.
48. Sica A., Schioppa T., Mantovani A., Allavena P. Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy. Eur. J. Cancer 2006, 42:717-727.
49. Stoll G., Jander S., Schroeter M. Cytokines in CNS disorders: neurotoxicity versus neuroprotection. J. Neural Transm. Suppl. 2000, 59:81-89.
50. Szabo S.J., Kim S.T., Costa G.L., Zhang X., Fathman C.G., Glimcher L.H. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 2000, 100:655-669.
51. Teng Y.D., Mocchetti I., Wrathall J.R. Basic and acidic fibroblast growth factors protect spinal motor neurones in vivo after experimental spinal cord injury. Eur. J. Neurosci. 1998, 10:798-802.
52. Thawer S.G., Mawhinney L., Chadwick K., de Chickera S.N., Weaver L.C., Brown A., Dekaban G.A. Temporal changes in monocyte and macrophage subsets and microglial macrophages following spinal cord injury in the Lys-Egfp-ki mouse model. J. Neuroimmunol. 2013, 261:7-20.
53. Vereyken E.J., Heijnen P.D., Baron W., de Vries E.H., Dijkstra C.D., Teunissen C.E. Classically and alternatively activated bone marrow derived macrophages differ in cytoskeletal functions and migration towards specific CNS cell types. J. Neuroinflammation 2011, 8:58.
54. Wang Y., Wang Y.P., Zheng G., Lee V.W., Ouyang L., Chang D.H., Mahajan D., Coombs J., Wang Y.M., Alexander S.I., Harris D.C. Ex vivo programmed macrophages ameliorate experimental chronic inflammatory renal disease. Kidney Int. 2007, 72:290-299.
55. Weisser S.B., McLarren K.W., Kuroda E., Sly L.M. Generation and characterization of murine alternatively activated macrophages. Methods Mol. Biol. 2013, 946:225-239.
56. Wu K.L., Chan S.H., Chao Y.M., Chan J.Y. Expression of pro-inflammatory cytokine and caspase genes promotes neuronal apoptosis in pontine reticular formation after spinal cord transection. Neurobiol. Dis. 2003, 14:19-31.
57. Wucherpfennig K.W. Autoimmunity in the central nervous system: mechanisms of antigen presentation and recognition. Clin. Immunol. Immunopathol. 1994, 72:293-306.
58. Yang L., Jones N.R., Blumbergs P.C., Van Den Heuvel C., Moore E.J., Manavis J., Sarvestani G.T., Ghabriel M.N. Severity-dependent expression of pro-inflammatory cytokines in traumatic spinal cord injury in the rat. J. Clin. Neurosci. 2005, 12:276-284.
59. Zhang X.M., Lund H., Mia S., Parsa R., Harris R.A. Adoptive transfer of cytokine-induced immunomodulatory adult microglia attenuates experimental autoimmune encephalomyelitis in DBA/1 mice. Glia 2014, 62:804-817.
60. Zheng W., Flavell R.A. The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 1997, 89:587-596.